| Product NDC: | 64980-104 |
| Proprietary Name: | Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate |
| Non Proprietary Name: | Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate |
| Active Ingredient(s): | 155; 852; 130 mg/1; mg/1; mg/1 & nbsp; Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 64980-104 |
| Labeler Name: | Rising Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20120628 |
| Package NDC: | 64980-104-01 |
| Package Description: | 100 TABLET in 1 BOTTLE (64980-104-01) |
| NDC Code | 64980-104-01 |
| Proprietary Name | Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate |
| Package Description | 100 TABLET in 1 BOTTLE (64980-104-01) |
| Product NDC | 64980-104 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20120628 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | Rising Pharmaceuticals, Inc. |
| Substance Name | POTASSIUM PHOSPHATE, MONOBASIC; SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE |
| Strength Number | 155; 852; 130 |
| Strength Unit | mg/1; mg/1; mg/1 |
| Pharmaceutical Classes |